Liposomal conjugates for drug delivery to the central nervous system
Treatments of central nervous system (CNS) diseases often fail due to the blood-brain barrier. Circumvention of this obstacle is crucial for any systemic treatment of such diseases to be effective. One approach to transfer drugs into the brain is the use of colloidal carrier systems—amongst others,...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
1 April 2015
|
| In: |
Pharmaceutics
Year: 2015, Jahrgang: 7, Heft: 2, Pages: 27-42 |
| ISSN: | 1999-4923 |
| DOI: | 10.3390/pharmaceutics7020027 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.3390/pharmaceutics7020027 Verlag, lizenzpflichtig, Volltext: https://www.mdpi.com/1999-4923/7/2/27 |
| Verfasserangaben: | Frieder Helm, Gert Fricker |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1727146271 | ||
| 003 | DE-627 | ||
| 005 | 20230427022507.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 200817s2015 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3390/pharmaceutics7020027 |2 doi | |
| 035 | |a (DE-627)1727146271 | ||
| 035 | |a (DE-599)KXP1727146271 | ||
| 035 | |a (OCoLC)1341355080 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 32 |2 sdnb | ||
| 100 | 1 | |a Helm, Frieder |e VerfasserIn |0 (DE-588)1031276165 |0 (DE-627)736110119 |0 (DE-576)378714600 |4 aut | |
| 245 | 1 | 0 | |a Liposomal conjugates for drug delivery to the central nervous system |c Frieder Helm, Gert Fricker |
| 264 | 1 | |c 1 April 2015 | |
| 300 | |a 16 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 17.08.2020 | ||
| 520 | |a Treatments of central nervous system (CNS) diseases often fail due to the blood-brain barrier. Circumvention of this obstacle is crucial for any systemic treatment of such diseases to be effective. One approach to transfer drugs into the brain is the use of colloidal carrier systems—amongst others, liposomes. A prerequisite for successful drug delivery by colloidal carriers to the brain is the modification of their surface, making them invisible to the reticuloendothelial system (RES) and to target them to specific surface epitopes at the blood-brain barrier. This study characterizes liposomes conjugated with cationized bovine serum albumin (cBSA) as transport vectors in vitro in porcine brain capillary endothelial cells (PBCEC) and in vivo in rats using fluorescently labelled liposomes. Experiments with PBCEC showed that sterically stabilized (PEGylated) liposomes without protein as well as liposomes conjugated to native bovine serum albumin (BSA) were not taken up. In contrast, cBSA-liposomes were taken up and appeared to be concentrated in intracellular vesicles. Uptake occurred in a concentration and time dependent manner. Free BSA and free cBSA inhibited uptake. After intravenous application of cBSA-liposomes, confocal fluorescence microscopy of brain cryosections from male Wistar rats showed fluorescence associated with liposomes in brain capillary surrounding tissue after 3, 6 and 24 h, for liposomes with a diameter between 120 and 150 nm, suggesting successful brain delivery of cationized-albumin coupled liposomes. | ||
| 650 | 4 | |a blood-brain barrier | |
| 650 | 4 | |a brain capillary endothelial | |
| 650 | 4 | |a cationized bovine serum albumin | |
| 650 | 4 | |a liposomal conjugates | |
| 650 | 4 | |a liposomes | |
| 700 | 1 | |a Fricker, Gert |d 1956- |e VerfasserIn |0 (DE-588)1042227675 |0 (DE-627)768469465 |0 (DE-576)393783464 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Pharmaceutics |d Basel : MDPI, 2009 |g 7(2015), 2, Seite 27-42 |h Online-Ressource |w (DE-627)614096529 |w (DE-600)2527217-2 |w (DE-576)313958653 |x 1999-4923 |7 nnas |a Liposomal conjugates for drug delivery to the central nervous system |
| 773 | 1 | 8 | |g volume:7 |g year:2015 |g number:2 |g pages:27-42 |g extent:16 |a Liposomal conjugates for drug delivery to the central nervous system |
| 856 | 4 | 0 | |u https://doi.org/10.3390/pharmaceutics7020027 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://www.mdpi.com/1999-4923/7/2/27 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20200817 | ||
| 993 | |a Article | ||
| 994 | |a 2015 | ||
| 998 | |g 1042227675 |a Fricker, Gert |m 1042227675:Fricker, Gert |d 160000 |d 160100 |e 160000PF1042227675 |e 160100PF1042227675 |k 0/160000/ |k 1/160000/160100/ |p 2 |y j | ||
| 998 | |g 1031276165 |a Helm, Frieder |m 1031276165:Helm, Frieder |d 160000 |d 160100 |e 160000PH1031276165 |e 160100PH1031276165 |k 0/160000/ |k 1/160000/160100/ |p 1 |x j | ||
| 999 | |a KXP-PPN1727146271 |e 3740484462 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"person":[{"role":"aut","given":"Frieder","display":"Helm, Frieder","family":"Helm"},{"display":"Fricker, Gert","given":"Gert","role":"aut","family":"Fricker"}],"name":{"displayForm":["Frieder Helm, Gert Fricker"]},"physDesc":[{"extent":"16 S."}],"id":{"eki":["1727146271"],"doi":["10.3390/pharmaceutics7020027"]},"relHost":[{"pubHistory":["1.2009 -"],"part":{"extent":"16","pages":"27-42","issue":"2","year":"2015","text":"7(2015), 2, Seite 27-42","volume":"7"},"language":["eng"],"title":[{"title":"Pharmaceutics","title_sort":"Pharmaceutics"}],"note":["Gesehen am 28.05.14"],"disp":"Liposomal conjugates for drug delivery to the central nervous systemPharmaceutics","physDesc":[{"extent":"Online-Ressource"}],"id":{"zdb":["2527217-2"],"issn":["1999-4923"],"eki":["614096529"]},"type":{"media":"Online-Ressource","bibl":"periodical"},"recId":"614096529","origin":[{"publisherPlace":"Basel","dateIssuedDisp":"2009-","publisher":"MDPI","dateIssuedKey":"2009"}],"name":{"displayForm":["Molecular Diversity Preservation International"]}}],"note":["Gesehen am 17.08.2020"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"recId":"1727146271","origin":[{"dateIssuedKey":"2015","dateIssuedDisp":"1 April 2015"}],"title":[{"title_sort":"Liposomal conjugates for drug delivery to the central nervous system","title":"Liposomal conjugates for drug delivery to the central nervous system"}],"language":["eng"]} | ||
| SRT | |a HELMFRIEDELIPOSOMALC1201 | ||